Description

• Introduction

Novel drug delivery systems (NDDSs) are used in nanomedicine to get around the drawbacks of conventional dosage forms. Poor drug solubility, harmful side effects, a lack of site selectivity, an unpredictable release profile, and limited bioavailability are all linked to conventional formulations. Additionally, patients do not comply well with standard formulations due to their frequent administration rates. Due to their excellent efficacy and durability, NDDSs have recently attracted a lot of attention, namely in the fields of immunodeficiency disorders and cancer therapy (Faheem et al., 2020).

In the past few decades, considerable attention has been focused on the development of novel drug delivery system (NDDS) for herbal drugs. The novel carriers should ideally fulfill two prerequisites. Firstly, it should deliver the drug at a rate directed by the needs of the body, over the period of treatment. Secondly, it should channel the active entity of herbal drug to the site of action. Conventional dosage forms including prolonged-release dosage forms are unable to meet none of these (Setia et al., 2024).